Kayser MS, Dalmau J. Anti-NMDA receptor encephalitis, autoimmunity, and psychosis. Schizophr Res. 2016;176(1):36–40. https://doi.org/10.1016/j.schres.2014.10.007.

Article  PubMed  Google Scholar 

Liu CY, Zhu J, Zheng XY, Ma C, Wang X. Anti-N-methyl-D-Aspartate receptor encephalitis: a severe, potentially reversible autoimmune encephalitis. Mediat Inflamm. 2017; https://doi.org/10.1155/2017/6361479.

Article  Google Scholar 

Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10(1):63–74. https://doi.org/10.1016/S1474-4422(10)70253-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7(12):1091–8. https://doi.org/10.1016/S1474-4422(08)70224-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kayser MS, Titulaer MJ, Gresa-Arribas N, Dalmau J. Frequency and characteristics of isolated psychiatric episodes in anti-n-methyl-d-aspartate receptor encephalitis. JAMA Neurol. 2013;70(9):1133–9. https://doi.org/10.1001/jamaneurol.2013.3216.

Article  PubMed  Google Scholar 

Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12(2):157–65. https://doi.org/10.1016/S1474-4422(12)70310-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bacchi S, Franke K, Wewegama D, Needham E, Patel S, Menon D. Magnetic resonance imaging and positron emission tomography in anti-NMDA receptor encephalitis: a systematic review. J Clin Neurosci. 2018;52:54–9. https://doi.org/10.1016/j.jocn.2018.03.026.

Article  PubMed  Google Scholar 

Lei C, Chang X, Li H, Zhong L. Abnormal brain MRI findings in anti-N-methyl-d-aspartate receptor encephalitis and correlation with outcomes. Front Neurol. 2022;13:834929. https://doi.org/10.3389/fneur.2022.834929.

Article  PubMed  PubMed Central  Google Scholar 

Zhao YY, Han B, Qin CH, et al. Brain magnetic resonance imaging predictors in anti-N-methyl-D-aspartate receptor encephalitis. Ann Clin Transl Neurol. 2022;9(12):1974–84. https://doi.org/10.1002/acn3.51690.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jeannin-Mayer S, André-Obadia N, Rosenberg S, et al. EEG analysis in anti-NMDA receptor encephalitis: description of typical patterns. Clin Neurophysiol. 2019;130(2):289–96. https://doi.org/10.1016/j.clinph.2018.10.017.

Article  CAS  PubMed  Google Scholar 

Zhang L, Wu MQ, Hao ZL, et al. Clinical characteristics, treatments, and outcomes of patients with anti-n-methyl-d-aspartate receptor encephalitis: a systematic review of reported cases. Epilepsy Behav. 2017;68:57–65. https://doi.org/10.1016/j.yebeh.2016.12.019.

Article  PubMed  Google Scholar 

Remy KE, Custer JW, Cappell J, et al. Pediatric Anti-N-Methyl-d-Aspartate receptor encephalitis: a review with pooled analysis and critical care emphasis. Front Pediatr. 2017;5:250. https://doi.org/10.3389/fped.2017.00250.

Article  PubMed  PubMed Central  Google Scholar 

Al-Diwani A, Handel A, Townsend L, et al. The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data. Lancet Psychiatry. 2019;6(3):235–46. https://doi.org/10.1016/S2215-0366(19)30001-X.

Article  PubMed  PubMed Central  Google Scholar 

Loughan AR, Allen A, Perna R, Malkin MG. Anti-N-methyl-d-aspartate receptor encephalitis: a review and neuropsychological case study. Clin Neuropsychol. 2016;30(1):150–63. https://doi.org/10.1080/13854046.2015.1132772.

Article  PubMed  Google Scholar 

Finke C, Kopp UA, Scheel M, et al. Functional and structural brain changes in anti-n-methyl-d-aspartate receptor encephalitis. Ann Neurol. 2013;74(2):284–96. https://doi.org/10.1002/ana.23932.

Article  CAS  PubMed  Google Scholar 

Schmitt SE, Pargeon K, Frechette ES, Hirsch LJ, Dalmau J, Friedman D. Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology. 2012;79(11):1094–100. https://doi.org/10.1212/WNL.0b013e3182698cd8.

Article  PubMed  PubMed Central  Google Scholar 

Gillinder L, Warren N, Hartel G, Dionisio S, O’Gorman C. EEG findings in NMDA encephalitis—a systematic review. Seizure. 2019;65:20–4. https://doi.org/10.1016/j.seizure.2018.12.015.

Article  PubMed  Google Scholar 

Marques Macedo I, Gama Marques J. Catatonia secondary to anti-n-methyl-d-aspartate receptor (NMDARr) encephalitis: a review. CNS Spectr. 2020;25(4):475–92. https://doi.org/10.1017/S1092852919001573.

Article  PubMed  Google Scholar 

Sarkis RA, Coffey MJ, Cooper JJ, Hassan I, Lennox B. Anti-n-methyl-d-aspartate receptor encephalitis: a review of psychiatric phenotypes and management considerations: a report of the American Neuropsychiatric Association Committee on Research. J Neuropsychiatry Clin Neurosci. 2019;31(2):137–42. https://doi.org/10.1176/appi.neuropsych.18010005doi:10.3389/fped.2017.00250.

Article  PubMed  Google Scholar 

Espinola-Nadurille M, Flores-Rivera J, Rivas-Alonso V, Vargas-Cañas S, Fricchione GL, Bayliss L, Martinez-Juarez IE, Hernandez-Vanegas LE, Martinez-Hernandez R, Bautista-Gomez P, Solis-Vivanco R, Perez-Esparza R, Bustamante-Gomez PA, Restrepo-Martinez M, Ramirez-Bermudez J. Catatonia in patients with anti-NMDA receptor encephalitis. Psychiatry Clin Neurosci. 2019;73(9):574–80. https://doi.org/10.1111/pcn.12867.

Article  PubMed  Google Scholar 

Kleinig TJ, Thompson PD, Matar W, Duggins A, Kimber TE, Morris JG, Kneebone CS, Blumbergs PC. The distinctive movement disorder of ovarian teratoma-associated encephalitis. Mov Disord. 2008;23(9):1256–61. https://doi.org/10.1002/mds.22073.

Article  PubMed  Google Scholar 

Duan BC, Weng WC, Lin KL, Wong LC, Li ST, Hsu MH, Lin JJ, Fan PC, Lin MI, Chiu NC, Lin YC, Wang HS, Hung KL, Lee WT. Variations of movement disorders in anti-n-methyl-d-aspartate receptor encephalitis: a nationwide study in Taiwan. Medicine. 2016;95(37):e4365. https://doi.org/10.1097/MD.0000000000004365.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang L, Lu Y, Xu L, Liu L, Wu X, Zhang Y, Zhu G, Hong Z. Anti-n-methyl-d-aspartate receptor encephalitis with accompanying ovarian teratoma in female patients from East China: clinical features, treatment, and prognostic outcomes. Seizure. 2020;75:55–62. https://doi.org/10.1016/j.seizure.2019.12.016.

Article  CAS  PubMed  Google Scholar 

Armangue T, Moris G, Cantarín-Extremera V, Conde CE, Rostasy K, Erro ME, Portilla-Cuenca JC, Turón-Viñas E, Málaga I, Muñoz-Cabello B, Torres-Torres C, Llufriu S, González-Gutiérrez-Solana L, González G, Casado-Naranjo I, Rosenfeld M, Graus F, Dalmau J. Autoimmune post-herpes simplex encephalitis of adults and teenagers. Neurology. 2015;85(20):1736–43. https://doi.org/10.1212/WNL.0000000000002125.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Westman G, Studahl M, Ahlm C, Eriksson BM, Persson B, Rönnelid J, Schliamser S, Aurelius E. N‑methyl-d-aspartate receptor autoimmunity affects cognitive performance in herpes simplex encephalitis. Clin Microbiol Infect. 2016;22(11):934–40. https://doi.org/10.1016/j.cmi.2016.07.028.

Article  CAS  PubMed  Google Scholar 

de Montmollin E, Demeret S, Brulé N, Conrad M, Dailler F, Lerolle N, Navellou JC, Schwebel C, Alves M, Cour M, Engrand N, Tonnelier JM, Maury E, Ruckly S, Picard G, Rogemond V, Magalhaes É, Sharshar T, Timsit JF, Honnorat J, ENCEPHALITICA Study Group. Anti-n-methyl-d-aspartate receptor encephalitis in adult patients requiring intensive care. Am J Respir Crit Care Med. 2017;195(4):491–9. https://doi.org/10.1164/rccm.201603-0507OC.

Article  PubMed  Google Scholar 

Peer M, Prüss H, Ben-Dayan I, Paul F, Arzy S, Finke C. Functional connectivity of large-scale brain networks in patients with anti-NMDA receptor encephalitis: an observational study. Lancet Psychiatry. 2017;4(10):768–74. https://doi.org/10.1016/S2215-0366(17)30330-9.

Article  PubMed  Google Scholar 

Bost C, Chanson E, Picard G, Meyronet D, Mayeur ME, Ducray F, Rogemond V, Psimaras D, Antoine JC, Delattre JY, Desestret V, Honnorat J. Malignant tumors in autoimmune encephalitis with anti-NMDA receptor antibodies. J Neurol. 2018;265(10):2190–200. https://doi.org/10.1007/s00415-018-8970-0.

Article  CAS  PubMed  Google Scholar 

Gibson LL, Pollak TA, Blackman G, Thornton M, Moran N, David AS. The psychiatric phenotype of anti-NMDA receptor encephalitis. J Neuropsychiatry Clin Neurosci. 2019;31(1):70–9. https://doi.org/10.1176/appi.neuropsych.17120343.

Article  PubMed  Google Scholar 

Zhang Y, Liu G, Jiang M, Chen W, He Y, Su Y. Clinical characteristics and prognosis of severe anti-n-methyl-d-aspartate receptor encephalitis patients. Neurocrit Care. 2018;29(2):264–72. https://doi.org/10.1007/s12028-018-0536-6.

Article  CAS  PubMed  Google Scholar 

Zhang L, Wu MQ, Hao ZL, Chiang SM, Shuang K, Lin MT, Chi XS, Fang JJ, Zhou D, Li JM. Clinical characteristics, treatments, and outcomes of patients with anti-n-methyl-d-aspartate receptor encephalitis: a systematic review of reported cases. Epilepsy Behav. 2017;68:57–65. https://doi.org/10.1016/j.yebeh.2016.12.019.

Article  PubMed  Google Scholar 

McKeon GL, Robinson GA, Ryan AE, Blum S, Gillis D, Finke C, Scott JG. Cognitive outcomes following anti-n-methyl-d-aspartate receptor encephalitis: a systematic review. J Clin Exp Neuropsychol. 2018;40(3):234–52. https://doi.org/10.1080/13803395.2017.1329408.

Article